What is Eclipse Clinical Research?
Eclipse Clinical Research operates as a critical intermediary in the pharmaceutical development lifecycle, specializing in the execution of rigorous clinical trials. Based in Tucson, Arizona, the company bridges the gap between research and development organizations and the patient population, ensuring that the safety and efficacy of new medical interventions are validated through stringent protocols. Their business model centers on providing a high-touch, participant-centric environment that facilitates the advancement of medical science while maintaining the highest standards of ethical oversight and volunteer care. By offering accessible participation pathways, the firm effectively accelerates the time-to-market for essential therapeutic innovations.
How much funding has Eclipse Clinical Research raised?
Eclipse Clinical Research has raised a total of $80K across 1 funding round:
Debt
$80K
Debt (2021): $80K with participation from PPP
Key Investors in Eclipse Clinical Research
PPP
Public-Private Partnership
What's next for Eclipse Clinical Research?
With the recent influx of capital, Eclipse Clinical Research is poised to transition into a more aggressive growth phase, likely focusing on the expansion of its physical research facilities and the integration of advanced data management technologies. The firm's strategic roadmap involves deepening its partnerships with global pharmaceutical entities to streamline the recruitment and screening processes. As the clinical research sector faces increasing pressure for faster, more reliable data, Eclipse is strategically aligned to capitalize on the demand for high-quality, compliant trial execution. Future initiatives will likely prioritize the scaling of their operational capacity to support more complex, multi-site international studies, thereby cementing their role as a pivotal player in the global medical research ecosystem.
See full Eclipse Clinical Research company page
